These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34843735)

  • 1. Blocking IAg
    Gupta S; Li D; Ostrov DA; Nguyen CQ
    Life Sci; 2022 Jan; 288():120182. PubMed ID: 34843735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjögren's syndrome.
    Shah M; Edman MC; Janga SR; Shi P; Dhandhukia J; Liu S; Louie SG; Rodgers K; Mackay JA; Hamm-Alvarez SF
    J Control Release; 2013 Nov; 171(3):269-79. PubMed ID: 23892265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.
    Meng Z; Klinngam W; Edman MC; Hamm-Alvarez SF
    PLoS One; 2017; 12(9):e0184781. PubMed ID: 28902875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of complement and B lymphocytes in Sjögren's syndrome-like autoimmune exocrinopathy of NOD.B10-H2b mice.
    Nguyen C; Cornelius J; Singson E; Killedar S; Cha S; Peck AB
    Mol Immunol; 2006 Mar; 43(9):1332-9. PubMed ID: 16221495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3.
    Nguyen CQ; Kim H; Cornelius JG; Peck AB
    J Immunol; 2007 Aug; 179(4):2318-29. PubMed ID: 17675493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjögren's syndrome.
    Akgul A; Maddaloni M; Jun SM; Nelson AS; Odreman VA; Hoffman C; Bhagyaraj E; Voigt A; Abbott JR; Nguyen CQ; Pascual DW
    Arthritis Res Ther; 2021 Apr; 23(1):99. PubMed ID: 33823920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of possible candidate genes regulating Sjögren's syndrome-associated autoimmunity: a potential role for TNFSF4 in autoimmune exocrinopathy.
    Nguyen CQ; Cornelius JG; Cooper L; Neff J; Tao J; Lee BH; Peck AB
    Arthritis Res Ther; 2008; 10(6):R137. PubMed ID: 19032782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Sjögren's syndrome and deficiency of ICA69.
    Winer S; Astsaturov I; Cheung R; Tsui H; Song A; Gaedigk R; Winer D; Sampson A; McKerlie C; Bookman A; Dosch HM
    Lancet; 2002 Oct; 360(9339):1063-9. PubMed ID: 12383988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal administration of alpha-fodrin inhibits experimental Sjögren's syndrome autoimmunity.
    He J; Zhao J; Li Z
    Arthritis Res Ther; 2008; 10(2):R44. PubMed ID: 18419828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease.
    Gao J; Killedar S; Cornelius JG; Nguyen C; Cha S; Peck AB
    J Autoimmun; 2006 Mar; 26(2):90-103. PubMed ID: 16413168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of CD40-CD154 pathway interactions suppresses ectopic lymphoid structures and inhibits pathology in the NOD/ShiLtJ mouse model of Sjögren's syndrome.
    Wieczorek G; Bigaud M; Pfister S; Ceci M; McMichael K; Afatsawo C; Hamburger M; Texier C; Henry M; Cojean C; Erard M; Mamber N; Rush JS
    Ann Rheum Dis; 2019 Jul; 78(7):974-978. PubMed ID: 30902822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
    Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
    Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4-STAT6 signal transduction-dependent induction of the clinical phase of Sjögren's syndrome-like disease of the nonobese diabetic mouse.
    Nguyen CQ; Gao JH; Kim H; Saban DR; Cornelius JG; Peck AB
    J Immunol; 2007 Jul; 179(1):382-90. PubMed ID: 17579059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune B Cell Repertoire in a Mouse Model of Sjögren's Syndrome.
    Sáez Moya M; Gutiérrez-Cózar R; Puñet-Ortiz J; Rodríguez de la Concepción ML; Blanco J; Carrillo J; Engel P
    Front Immunol; 2021; 12():666545. PubMed ID: 33968069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope Mapping of Pathogenic Autoantigens on Sjögren's Syndrome-Susceptible Human Leukocyte Antigens Using In Silico Techniques.
    Gupta S; Li D; Ostrov DA; Nguyen CQ
    J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35330015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with 60 kD Ro peptide produces different stages of preclinical autoimmunity in a Sjögren's syndrome model among multiple strains of inbred mice.
    Kurien BT; Dsouza A; Igoe A; Lee YJ; Maier-Moore JS; Gordon T; Jackson M; Scofield RH
    Clin Exp Immunol; 2013 Jul; 173(1):67-75. PubMed ID: 23607771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic background.
    Czerwinski S; Mostafa S; Rowan VS; Azzarolo AM
    Exp Eye Res; 2014 Nov; 128():15-22. PubMed ID: 25218176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artesunate inhibits Sjögren's syndrome-like autoimmune responses and BAFF-induced B cell hyperactivation via TRAF6-mediated NF-κB signaling.
    Zhan T; Wang B; Fu J; Shao Y; Ye L; Shi H; Zheng L
    Phytomedicine; 2021 Jan; 80():153381. PubMed ID: 33086170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two different types of sialoadenitis in the NOD- and MRL/lpr mouse models for Sjögren's syndrome: a differential role for dendritic cells in the initiation of sialoadenitis?
    van Blokland SC; van Helden-Meeuwsen CG; Wierenga-Wolf AF; Drexhage HA; Hooijkaas H; van de Merwe JP; Versnel MA
    Lab Invest; 2000 Apr; 80(4):575-85. PubMed ID: 10780673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel NOD-derived murine model of primary Sjögren's syndrome.
    Robinson CP; Yamachika S; Bounous DI; Brayer J; Jonsson R; Holmdahl R; Peck AB; Humphreys-Beher MG
    Arthritis Rheum; 1998 Jan; 41(1):150-6. PubMed ID: 9433880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.